2009 Vienna - European Society of Human Genetics
2009 Vienna - European Society of Human Genetics
2009 Vienna - European Society of Human Genetics
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Cancer cytogenetics<br />
(range: 3-19 vs. 2-31), and highest in AAIII (mean±SEM: 14.3±3.3,<br />
range: 2-47). The following imbalances were identified to be frequent in<br />
AAIII and more frequent in AII-short as compared to AII-long: Gain on<br />
7q (AAIII: 67%, AII-short: 67%, AII-long: 45%), loss on 10q (AAIII: 50%,<br />
AII-short: 44%, AII-long: 18%), loss on 14q (AAIII: 50%, AII-short: 33%,<br />
AII-long: 18%), loss on 19q (AAIII: 58%, AII-short: 44%, AII-long: 27%),<br />
gain on 20p (AAIII: 42%, AII-short: 33%, AII-long: 18%), gain on 20q<br />
(AAIII: 42%, AII-short: 22%, AII-long: 9%), and loss on 22q (AAIII: 33%,<br />
AII-short: 22%, AII-long: 0). In summary, AII from patients with short RFI<br />
seem to contain a higher average number <strong>of</strong> genomic imbalances per<br />
tumor than AII from patients with a long RFI. Furthermore, our data suggest<br />
that the presence <strong>of</strong> gains on 7q, 20p and 20q as well as losses on<br />
10q, 14q, 19q and 22q may be linked to poor prognosis in AII.<br />
P07.04<br />
Detection <strong>of</strong> a High incidence <strong>of</strong> chromosomal Rearrangements<br />
in the centromeric Regions <strong>of</strong> gastric adenocarcinoma subjects<br />
from coimbatore south india<br />
P. Manikantan, V. Balachandar, K. Sasikala, B. Lakshmankumar, S. Mohanadevi;<br />
Bharathiar University, Coimbatore, India.<br />
Gastric cancer is the third most frequent type <strong>of</strong> neoplasia and the<br />
second most important cause <strong>of</strong> cancer-related death in the world.. To<br />
evaluate chromosomal aberrations implicated in gastric carcinogenesis,<br />
we analyzed 24 samples <strong>of</strong> gastric adenocarcinoma by fluorescence<br />
in situ hybridization using a chromosome 8 a-satellite probe and<br />
by direct chromosomal analysis techniques. Trisomy 8 was the main<br />
finding <strong>of</strong> this study, observed in all cases. There was no significant difference<br />
between chromosome 8 ploidy and localization, stage, or histological<br />
type <strong>of</strong> adenocarcinoma in the experimental subjects. The high<br />
incidence <strong>of</strong> alterations we found in chromosome 8 may be a regional<br />
characteristic, related to the high incidence <strong>of</strong> this neoplasm in gastric<br />
adenocarcinoma and a strong influence <strong>of</strong> external factors, such as<br />
food habits. This aberration may comprise a cytogenetic subgroup <strong>of</strong><br />
this neoplasm. Additional investigations are necessary to confirm the<br />
involvement <strong>of</strong> chromosome 8 and to identify genes in this chromosome<br />
related to gastric carcinogenesis. An increased copy number <strong>of</strong><br />
chromosome 8 needs to be better investigated in other stages <strong>of</strong> gastric<br />
neoplasias, to clarify whether it is an etiologic cause <strong>of</strong> malignant<br />
transformation or a consequence <strong>of</strong> the proliferation process.<br />
P07.05<br />
the development <strong>of</strong> HPV cervical cancer is associated with the<br />
involvement <strong>of</strong> multiple genes<br />
S. N. Kokkinou, K. Tzanidakis, A. Lindou;<br />
Cytogenetic Unit, Sismanoglion General Hospital, Halandri, Greece.<br />
Introduction: Cervical cancer is a worldwide disease and infection with<br />
high-risk human papillomavirus(HPV)is the major risk factor <strong>of</strong> it’s development.<br />
Aim Of The Study: In cervical cancer <strong>of</strong> HPV infected women the<br />
ATM,p53,EGFR,HER-2/TOP2A genes,are involved and affect the outcome<br />
<strong>of</strong> the disease.<br />
Recently two human telomerase gene locus,the hTERT(5p15.2)and<br />
hTERC(3q26)play a critical role.<br />
Patients: Twenty women 22-51ys were transferred to Cytogenetic unit.<br />
All they had a family history <strong>of</strong> breast/ovarian cancer and they had a<br />
chronic cervical inflammation.<br />
They got a new PAPtest looking for the presence <strong>of</strong> oncogenic HPV<br />
infection.<br />
Methods: Peripheral blood lymphocytes(PB )were cultured using<br />
standard techniques.Thirty GTG banded metaphases were analyzed<br />
(ISCN2005). For FISH we used 2 panel probes(1)LSI HER-1,HER2/<br />
TOP2A/<br />
CEP17,LSI p53,ATM(VYSIS).<br />
(2)hTERT(5p15)/EGRI(5q31)and hTERC(3q26),C-MYC(8q24),SE<br />
triple color probe(KREATECH).<br />
Two hundred interphase nuclei were counted for any single probe in<br />
all.<br />
Results: High riskHPV16/18 was detected in the 2youngest pts,the intermediate<br />
risk 35/39in10 and the low risk type 6/11in 8.<br />
The karyotypes looked normal.<br />
In all there were circulating cells with amplification <strong>of</strong> EGFR,HER-2/<br />
TOP2A gene,and deletion <strong>of</strong> p53/ATM gene.<br />
From the 2 nd panel <strong>of</strong> probes there was amplified C-MYC,3q26 and<br />
5p15.2region.<br />
Conclusions: (1)The presence <strong>of</strong> amplified genes in the PB lymphocytes<br />
suggest that there are malignant circulating cells.<br />
(2)During their 2ys follow-up none has developed a definite cancer so<br />
a permanent oncogenic stimulus or other co-factors are required for<br />
neoplastic transformation.<br />
(3)The gains <strong>of</strong> 5p15.2 and 3q26 are interesting given the presence<br />
<strong>of</strong> the hTRand hTERT genes,which can be the target for amplification<br />
during the transformation <strong>of</strong> human malignacies.<br />
P07.06<br />
mosaic isochromosome Xp in a girl with short stature and bone<br />
marrow failure<br />
C. Morerio, E. Tavella, A. Casalaro, C. Dufour, C. Panarello, E. Tassano;<br />
IRCCS Istituto G.Gaslini, Genova, Italy.<br />
A 18-month girl, second daughter <strong>of</strong> unrelated parents, was diagnosed<br />
with bone marrow (BM) failure and treated with cyclosporine ad steroids,<br />
with partial response. At 6 years <strong>of</strong> age, she was referred to<br />
us for anemia, low white bood cell and platelet counts. BM aspirate<br />
showed no blasts or myelodysplasia; bone biopsy showed reduced<br />
cellularity and megakaryocyte number. Her height was